{ "items" : [
    { "id" : "http://dbpedia.org/resource/Denosumab"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Denosumab is a fully human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone. It was developed by the biotechnology company Amgen.In June 2010, denosumab was approved by the U.S." ] ,
        "http://dbpedia.org/ontology/atcPrefix" : [ "M05" ] ,
        "http://dbpedia.org/ontology/atcSuffix" : [ "BX04" ] ,
        "http://dbpedia.org/ontology/casNumber" : [ "615258-40-7" ] ,
        "http://dbpedia.org/ontology/fdaUniiCode" : [ "4EQZ6YO2HI"] } } }
